Screening of CTP Synthase Inhibitors to Augment Antiviral Drugs for the Synergistic Treatment of COVID-19 Infections Dr. Stephen Bearne Dalhousie University Total Project Value: $25,000 Funding Partners: Nova Scotia Health Research Coalition, Nova Scotia Health, Dalhousie University, Dalhousie Medical Research Foundation (DMRF), QEII Health Sciences Centre Foundation, IWK Foundation, IWK Health Centre, Dartmouth General Hospital Foundation (DGHF) Key Words: COVID-19, screening, infections, virus, antiviral drug compounds
- Funded by Research Nova Scotia
- Total publications:0 publications
Grant search
Key facts
Disease
COVID-19start year
2021Funder
Research Nova ScotiaPrincipal Investigator
Dr. Stephen BearneResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
COVID-19, screening, infections, virus, antiviral drug compounds